Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection
By R. Schooley, B. Biswas, J. Gill, A. Hernandez-Morales, J. Lancaster, L. Lessor, J. Barr, S. Reed, Forest Rohwer, Sean Benler and 24 more. Antimicrobial Agents and Chemotherapy, 2017
1,039 citations recorded by the source corpus.
Subfields: Ecology, Infectious Diseases, Molecular Medicine
View Paper: https://www.semanticscholar.org/paper/2fa2a62929ce96aa341c8fd472dc3df22ddc267d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Ecology
In Infectious Diseases
In Molecular Medicine
Citations in the corpus
- Impact of antibiotics on the human microbiome and consequences for host health (2022, background): “A report based on using perso- nalized phage therapy for treating a patient with multidrug re- sistant A. baumannii reported clearance of infection and success of the treatment (Schooley et al., 2017).”
- Phage Therapy in the Postantibiotic Era (2019, background): “(78) reported the first case of successful intravenous and intracavitary”
- Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease (2019, positive): “The results of these studies, while mixed in terms of efficacy, strongly suggest that phage treatment offers a safe alternative to antibiotics 26,27 .”
- Engineering Phage Host-Range and Suppressing Bacterial Resistance through Phage Tail Fiber Mutagenesis (2019, background): “Moreover, phage therapy has successfully been used for compassionate care cases when all antibiotic treatment options have failed (Dedrick et al., 2019; Schooley et al., 2017).”
- Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria. (2019, positive): “Recent case studies show that in principle either a single phage or phage-cocktail approach might work (see Clinical Cases) (Chan et al., 2018; Schooley et al., 2017).”